Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Dr. Kolb is a specialist in Pulmonary and Critical Care Medicine with special focus on pulmonary vascular disease and Critical Care Medicine. He is an expert in the diagnosis and management of all forms of chronic pulmonary hypertension, and has special interests in the chronic thromboembolic pulmonary hypertension, peri-operative and ICU management of pulmonary hypertension. He is an expert in the management of acute pulmonary embolism, leads the Johns Hopkins Pulmonary Embolism Response Team, and provides longitudinal ambulatory follow-up for patients after acute pulmonary embolism. He has extensive experience in the diagnosis and management of all forms of acute respiratory failure and other life-threatening conditions such as shock, gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis and hyperosmolar states, and acute kidney and liver failure. Dr. Kolb is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Lung Transplant.

Dr. Catherine Simpson is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine, pulmonary and critical care medicine, and pulmonary vascular diseases. Dr. Simpson earned her M.D. from the Louisiana State University School of Medicine. She completed her residency at Johns Hopkins, where she also performed a fellowship in pulmonary and critical care medicine and earned her M.H.S. degree from the Johns Hopkins Bloomberg School of Public Health. Dr. Simpson is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, and Scleroderma.

Bradley Maron is a Cardiologist in Baltimore,, Maryland. Dr. Maron is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Mark Gladwin is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Gladwin is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Heart Failure with Preserved Ejection Fraction (HFpEF), Cerebral Hypoxia, Embolectomy, and Splenectomy.

Gautam Ramani is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Baltimore, Maryland. Dr. Ramani is rated as an Elite provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cardiomyopathy, Embolectomy, and Aortic Valve Replacement. Dr. Ramani is currently accepting new patients.

Dr. Allen Everett is a professor of pediatrics at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general pediatric cardiology. Dr. Everett earned his M.D. from East Tennessee State University. He completed his residency in pediatrics and fellowship in pediatric cardiology at the University of Virginia. Dr. Everett joined the Johns Hopkins faculty in 2003. He has become the program leader at Johns Hopkins in pediatric biomarker discovery, with a particular focus on brain injury, pulmonary hypertension and effects of medical plastics exposure on congenital heart disease outcomes. He is the principal investigator (PI) or co-PI on multiple NIH- funded R01 studies. Dr. Everett also serves as the director of the Pediatric Proteome Center. Dr. Everett is an author of over 140 peer review papers, three book chapters, editor/author of the Illustrated Field Guide to Congenital Heart Disease and Repair, now in its fourth edition, and senior associate editor for the journal, Cardiology in the Young. He is a co-developer of PedCathTM cardiac catheterization software with Scientific Software Solutions which has been translated into five languages, has five US biomarker patents filed and brain injury biomarkers licensed to ImmunArray, Ltd. Dr. Everett is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Hypertension, Pulmonary Hypertension, Congenital Heart Disease (CHD), Heart Bypass Surgery, and Heart Transplant.

Dr. Robert Weiss is a Clarence Doodeman professor of cardiology as well as a professor of medicine and radiology at the Johns Hopkins University School of Medicine. Dr. Weiss directs a multi-disciplinary team at Johns Hopkins as well as collaborators at Cedars Sinai Medical Center in Los Angeles are dedicated to identifying the most important clinical, genetic, structural, contractile and metabolic causes of sudden cardiac death as well as the means to reverse the underlying pathology and lower risk. His research interests include energetic consequences and causes of heart failure, predictors of sudden cardiac death, non-invasive magnetic resonance, role of creatine kinase in heart failure, spectroscopy and imaging, coronary endothelial function and small animal cardiovascular imaging. Dr. Weiss received an undergraduate degree in physics form Dickinson College and a medical degree from Pennsylvania State University College of Medicine AOA Hershey Medical Center before joining Johns Hopkins in 1983 as an intern and assistant resident. Dr. Weiss has published extensively and has most recently been awarded a fellowship with the International Society of Magnetic Resonance in Medicine. Dr. Weiss is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Heart Attack, Pulmonary Veno-Occlusive Disease, and Apoplexy.

Dr. Monica Mukherjee is an adult cardiologist and an Associate Professor of Medicine at the Johns Hopkins University Division of Cardiology and specializes in advanced cardiac imaging. She serves as Medical Director of the Echocardiography Lab at Johns Hopkins Bayview Medical Center, and as Associate Director of the Johns Hopkins Echocardiography program across the institution. Dr. Mukherjee graduated Summa Cum Laude with dual Bachelors of Science in Psychology and Behavioral Neurosciences from the University of Florida. She received her Doctorate in Medicine from the George Washington University in Washington, DC, and internal medicine residency at Drexel University, before returning to George Washington to complete her fellowship in cardiovascular disease. She has a MPH from the Johns Hopkins Bloomberg School of Public Health with a special concentration in Epidemiological and Biostatistical Methods for Public Health and Clinical Research. Dr. Mukherjee has an accomplished academic career with multiple research awards focused on right ventricular remodeling in heart failure, pulmonary hypertension, and scleroderma. She was the recipient of the 2020 Johns Hopkins University Clinician Scientist Award and also has been funded by the National Institutes of Health, the Scleroderma Foundation, and the CHEST Foundation. She was awarded the Top 25 Young Investigators Award from the American Society of Echocardiography in 2016. Dr. Mukherjee is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Pulmonary Hypertension, Heart Attack, Systemic Sclerosis (SSc), Tissue Biopsy, and Pacemaker Implantation.

Vineet Agrawal is a Cardiologist in Baltimore, Maryland. Dr. Agrawal is rated as a Distinguished provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Pulmonary Hypertension, Heart Failure with Preserved Ejection Fraction (HFpEF), Hypertension, Prostatectomy, and Endoscopy.

Aparna Balasubramanian is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Balasubramanian is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Veno-Occlusive Disease, Emphysema, and Lung Transplant.

Dr. Katherine Wu is a general cardiologist for the Heart and Vascular Institute at Johns Hopkins Medicine with an interest in caring for patients with cardiomyopathies, coronary artery disease, and valvular heart disease as well as those interested in cardiovascular prevention. She has additional expertise in non-invasive cardiology imaging techniques. Dr. Wu received her medical degree from the University of Pennsylvania Health System School of Medicine, and completed her residency and a cardiology fellowship at the Johns Hopkins University School of Medicine. She joined the School of Medicine faculty in 2000. Dr. Wu's research interests include improving individualized risk prediction for sudden cardiac death and heart failure by developing and validating methods that incorporate novel cardiac imaging indices. Her lab is funded by the NIH/NHLBI. Dr. Wu has more than 70 peer-reviewed publications and serves on the editorial board of the Journal of Cardiovascular Magnetic Resonance and Circulation Cardiovascular Imaging and is a standing member of the NIH Clinical and Integrative Cardiovascular Sciences Study Section. Dr. Wu is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Cardiomyopathy, Atrial Fibrillation, Heart Attack, and Pulmonary Hypertension.

Dr. J. Michael Collaco is a professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical specialty is pediatric pulmonary medicine, including chronic lung disease of premature infants, lung disease in medically complex patients including ventilators and tracheostomies, hereditary hemorrhagic telangiectasia, aerodigestive disorders, and general pediatric pulmonary conditions. He sees patients inpatient and outpatient at Johns Hopkins (East Baltimore campus), inpatient and outpatient at Mount Washington Pediatric Hospital, and inpatient at Kennedy Krieger Institute. Dr. Collaco attended Yale University for undergraduate studies and received his M.D. and M.S. (Anatomy) from Case Western University School of Medicine in Cleveland, Ohio. He completed his pediatric residency, pediatric pulmonary fellowship, M.B.A., M.P.H., and Ph.D. (Clinical Epidemiology) at the Johns Hopkins University. Dr. Collaco joined the Johns Hopkins faculty in 2008. His primary research interest is in the epidemiology of pediatric respiratory diseases, with a focus on environmental risk factors for cystic fibrosis and bronchopulmonary dysplasia as well as a special interest in the effects of secondhand smoke and electronic cigarette emissions. He has published over 140 peer-reviewed articles. Dr. Collaco is a member of the Cystic Fibrosis Research Development Center and the Hereditary Hemorrhagic Telangiectasia Center of Excellence. He has been recognized by Johns Hopkins with the John C. Hume Scholarship, the Francis F. Schwentker Research Award, and the Robert Dyar Award. Dr. Collaco is a fellow of the American Academy of Pediatrics. Dr. Collaco is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Bronchopulmonary Dysplasia, Cystic Fibrosis, Pulmonary Hypertension, Pseudomonas Stutzeri Infections, and Gastrostomy.

Dr. Melanie Kandt Nies is a pediatric cardiologist specializing in congenital heart disease, echocardiography and pulmonary hypertension. She completed her medical school education at the University of North Carolina School of Medicine, followed by her residency and pediatric cardiology and fellowship at the Johns Hopkins Children’s Center. Dr. Nies' research focuses on non-invasive diagnosis, therapeutic monitoring and prognosis of pulmonary hypertension using non-invasive imaging and biomarkers. She has advanced training in echocardiography and proteomic biomarker discovery. She works as part of a multidisciplinary team at Johns Hopkins Hospital, caring for patients with pulmonary hypertension, and as part of Kennedy Krieger Institute’s multidisciplinary team for the care of patients with congenital diaphragmatic hernia. Dr. Nies lives in Baltimore City with her husband and two young sons. She and her family are fans of the Baltimore Orioles and Ravens, and enjoy the many city parks, food and cultural activities of Baltimore City. Dr. Nies is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Hypertension, Pulmonary Hypertension, Cerebral Hypoxia, and High Blood Pressure in Infants.

Dr. Damarla is a specialist in Pulmonary and Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis and hyperosmolar states, and shock from sepsis, hypovolemia, and heart disease. Dr. Damarla is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Cerebral Hypoxia, Pulmonary Hypertension, Acute Respiratory Distress Syndrome (ARDS), and Pneumonia.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Sarah Khan is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Pulmonary Hypertension. Her top areas of expertise are Venous Thromboembolism (VTE), Pulmonary Hypertension, Interstitial Lung Disease, and Acute Interstitial Pneumonia.